Abstract:Background Alopecia areata (AA) is an autoimmune non-scarring alopecia that affects the scalp or any hair-bearing areas in the body. The pathophysiology of AA is complex, but Th1, Th2, and Th17 cytokines dysregulation, as well as chemokines, immunoglobulins and other biomarkers have been shown to play a role in the pathogenesis of the disease. Objective To conduct a systematic review and Meta-analysis to identify biomarkers that reflect AA activity and severity that could be used to better assess disease activity and response in both trials and clinical practice. Methods A literature search was conducted using the PUBMED, EMBASE and the Cumulative Index to Nursing and Allied Health Literature (CINAHL) from inception to December 2021. Articles reporting on associations between AA and serum clinical biomarkers (cytokines, chemokines, antibodies, immunoglobulins, and others) were included. Serum biomarkers were identified in patients with AA and were correlated with disease severity and patient characteristics (ex. age, sex, comorbidities). The quality of the studies was assessed using the National Heart, Lung, and Blood Institute's Quality Assessment Tool for Case-Control Studies. Meta-analysis pooling of the standardized mean differences (SMD) by the method of Cohen using the common-effect inverse-variance model was performed. For the Meta-analysis, data was pulled for all the markers with a minimum of 4 studies with means and standard deviations. Analysis of data reported as Median with range or inter-quartile range (IQR) revealed that the data was too skewed to recommend calculation and use of mean with standard deviation (SD). If the data were not skewed, mean and SD were calculated. Results One thousand seven hundred fourteen studies were screened, with 91 included, reporting on a total of 52 biomarkers. Meta-analyses revealed pooled SMD that were significant for interleukin 6 (IL6), C-reactive protein (CRP) and vitamin D. Conclusions Serum IL6 and CRP levels are significantly increased in patients with AA compared to healthy age and sex matched controls. Conversely, serum vitamn D levels are significantly decreased in patients with AA compared to healthy age and sex matched controls. This data has the potenail to influence the clinical guidelines for the diagnostic workup of AA to include testing the serum levels of CRP and vitamin D.

Serum CCL20: A novel potential marker of cardiovascular risk in alopecia areata patients

Linear Alopecia Areata.

C‐reactive protein as a novel biomarker for vitamin D deficiency in alopecia areata

Serum Interleukin 17 as a Marker for Alopecia Areata Severity: A Case-Control Study

Serum interleukin-15 is a marker of alopecia areata severity

Elevation of circulating DNAs of disease-associated cytokines in serum cell-free DNA from patients with alopecia areata

Biomarkers in alopecia Areata: A systematic review and meta-analysis.

Evaluation of serum homocysteine, high-sensitivity CRP, and RBC folate in patients with alopecia areata

LncRNA NEAT1 and miRNA 101 as potential diagnostic biomarkers in patients with alopecia areata

The value of immunohistochemical expression of SOX9 and CD34 in alopecia areata

Novel potential therapeutic targets of alopecia areata

Stratification of alopecia areata reveals involvement of CD4 T cell populations and altered faecal microbiota

Evaluation of several immune and inflammatory indicators and their association with alopecia areata

Complete Blood Collection-based Systemic Inflammation Biomarkers as a Severity Biomarker in Alopecia Areata: A Cross-sectional Study

Role of adiponectin and leptin in patients with alopecia areata with scalp hair loss

Alopecia areata: Disease characteristics, clinical evaluation, and new perspectives on pathogenesis

Study of skin expression of Micro RNA 203 in patients with Alopecia areata

JAK Inhibitors for the Treatment of Alopecia Areata

Autoantigen Discovery in the Hair Loss Disorder, Alopecia Areata: Implication of Post-Translational Modifications

Evaluation of serum 25-hydroxy vitamin D levels in alopecia areata of scalp: a cross sectional observational study

Emerging drugs for the treatment of alopecia areata